External Resources

Shipping Information- Information on shipping requirements including applicability, training, and resources provided by the Environmental Health & Safety Department

Frequently Asked Questions (FAQs) of Interest to IBCs and recombinant DNA researchers(information provided by the NIH OBA).
Frequently Asked Questions (FAQs) about the NIH Review Process for Human Gene Transfer Trials(information provided by the NIH OBA).

NIH Guidelines for Research Involving Recombinant DNA Molecules (April 2002):

Section I-E.- General Definitions


Section III-A.- Experiments that Require Institutional Biosafety Committee Approval, RAC Review, and NIH Director Approval Before Initiation


Section III-D.- Experiments that Require Institutional Biosafety Committee Approval Before Initiation


Section III-F.- Exempt Experiments


Section IV-B-7- Principal Investigator (PI) Responsibilities


Appendix B- Classification of Human Etiologic Agents on the Basis of Hazard


Appendix C- Exemptions under Section III-F-6


Appendix G-II.- Physical Containment Levels


Appendix M- Points to Consider in the Design and Submission of Protocols for the Transfer of Recombinant DNA Molecules into One or More Human Research Participants

Other Resources

Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition
(Updated 7 Oct 2008)

Health Canada's Material Safety Data Sheets

NIH Recombinant DNA Advisory Committee's Guidance on the Biosafety of Lentiviral Vectors